Categories: Research

New clues in the hunt for Alzheimer’s therapies

Pharmaceutical chemist Arkin and neurologist Grinberg discover a new protein aggregate in Alzheimer’s disease.

Díaz honored with Edison T. Uno Award for Public Service

Tetrad graduate student recognized for efforts to support marginalized students at UCSF

UCSF QBI Coronavirus Research Group awarded $67.5 million to develop therapies for future pandemics

Award is the largest NIH grant in UCSF history

Dresser follows in Giacomini’s footsteps as an advocate for DEI in science and industry

Dresser is the first openly-LGBTQ president of the ASCPT

2022 Koda-Kimble Seed Awards fuel the School’s most innovative ideas

This year’s Seed Awards will support projects ranging from the discovery sciences and patient care to sustainability and diversity, equity, and inclusion

UCSF School of Pharmacy leads in NIH funding for the 42nd straight year

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Shipman lab pioneers more efficient genome editing

Recent findings from the laboratory of Seth Shipman, PhD, show that a type of bacterial DNA known as a retron can be harnessed to dramatically improve genome editing.

Beyond the spike protein

Findings from QBI point to a host of viral proteins that enable SARS-CoV-2 variants to evade the immune system.

UCSF researchers develop a new drug regimen to combat malaria in children

Study shows that monthly doses of two common anti-malarial drugs for the first few years of life can provide 95 percent protection against the disease.

Pages